We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The ongoing debate over the new Medicare discount drug cards boiled over into the presidential race yesterday, with Democratic candidate John Kerry’s campaign alleging that several of the companies offering the cards had been charged with fraud and that some had made political contributions to the president’s re-election campaign.
Following a small proof-of-concept pilot, PhRMA will launch in July a large market test of the technology solutions for its paperless labeling initiative.
The FDA’s Division of Drug Marketing, Advertising and Communication (DDMAC) has cited Abbott Laboratories for promotional materials that were misleading and lacking complete risk information about the company’s HIV/AIDS drug Norvir.
GlaxoSmithKline (GSK) has been ordered to immediately cease broadcasting of a television advertisement for Paxil CR that suggests the antidepressant is useful for people who do not generally require psychopharmacological treatment.
The FDA should issue regulations that would eliminate a brand company’s ability to license an authorized generic product until the first generic applicant’s 180-day exclusivity period has expired, the Generic Pharmaceutical Association (GPhA) has told the agency.
Members of the FDA's Pulmonary-Allergy Drugs Advisory Committee have suggested setting a 2006 deadline for phasing out chlorofluorocarbon (CFC)-propelled albuterol metered dose inhalers (MDIs), in anticipation of the agency publishing a proposed rule this week on the matter.
Beginning with today's issue, your FDAnews publication will be
delivered to you in a new, interactive PDF format designed to eliminate the need for scrolling through the document to find a story or to read the continuation of an article.
Beginning with today's issue, your FDAnews publication will be delivered to you in a new, interactive PDF format designed to eliminate the need for scrolling through the document to find a story or to read the continuation of an article.
The pharmaceutical industry is not complying with a law that requires drugmakers to report data on industry-sponsored cancer clinical trials to a federal website, according to a powerful House lawmaker.